Maximal Cytoreductive Surgery as a Reasonable Therapeutic Alternative for Recurrent Endometrial Carcinoma

Author： Scarabelli C.   Campagnutta E.   Giorda G.   DePiero G.   Sopracordevole F.   Quaranta M.   DeMarco L.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.70, Iss.1, 1998-07, pp. : 90-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stage IVB Endometrial Carcinoma: The Role of Cytoreductive Surgery and Determinants of Survival

By Bristow R.E.   Zerbe M.J.   Rosenshein N.B.   Grumbine F.C.   Montz F.J.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 85-91

Elsevier

Access to resources Recommend Favorite

Secondary Cytoreductive Surgery for Patients with Recurrent Epithelial Ovarian Carcinoma

By Scarabelli C.   Gallo A.   Carbone A.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 504-512

Elsevier

Access to resources Recommend Favorite

Secondary Cytoreductive Surgery in Patients with Platinum-Sensitive Recurrent Ovarian Cancer

By Benedetti Panici Pierluigi   De Vivo Antonio   Bellati Filippo   Manci Natalina   Perniola Giorgia   Basile Stefano   Muzii Ludovico   Angioli Roberto  

Annals of Surgical Oncology, Vol. 14, Iss. 3, 2007-03 ,pp. : 1136-1142

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Cytoreductive Surgery in the Management of Stage IV Uterine Papillary Serous Carcinoma

By Bristow R.E.   Duska L.R.   Montz F.J.  

Gynecologic Oncology, Vol. 81, Iss. 1, 2001-04 ,pp. : 92-99

Elsevier

Access to resources Recommend Favorite

Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?

By  

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 117-119

Informa Healthcare

Access to resources Recommend Favorite